Overview Fundamentals API Earnings EOD API Sample Code Pricing

Caribou Biosciences Inc (CRBU NASDAQ) stock market data APIs

$2.5 0.01(0.4%) as of July 26, 2024
Price chart is built with Anychart

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Caribou Biosciences Inc Financial Data Overview

2.49
2.5
-
2.575
2.44
1.5-8.33
220 M
90 318 K
33 404 K
-0.46
2.284
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CRBU',
Type: 'Common Stock',
Name: 'Caribou Biosciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG008G28LJ5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1619856',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-23',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Caribou Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 33 404 K
  • EBITDA -127 299 000
  • Earnings Per Share -1.38
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Caribou Biosciences Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.4105

Get Caribou Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com